key: cord-0872891-1gziw062
authors: Gao, Xin; Liu, Yuan; Zou, Shaohui; Liu, Pengqin; Zhao, Jing; Yang, Changshun; Liang, Mingxing; Yang, Jinlian
title: Genome‐wide screening of SARS‐CoV‐2 infection‐related genes based on the blood leukocytes sequencing data set of patients with COVID‐19
date: 2021-05-28
journal: J Med Virol
DOI: 10.1002/jmv.27093
sha: 9632f315443bcccdb8397a32ba1440f920633e5e
doc_id: 872891
cord_uid: 1gziw062

Coronavirus disease 2019 (COVID‐19) is a global epidemic disease caused by a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), causing serious adverse effects on human health. In this study, we obtained a blood leukocytes sequencing data set of COVID‐19 patients from the GEO database and obtained differentially expressed genes (DEGs). We further analyzed these DEGs by protein–protein interaction analysis and Gene Ontology enrichment analysis and identified the DEGs closely related to SARS‐CoV‐2 infection. Then, we constructed a six‐gene model (comprising IFIT3, OASL, USP18, XAF1, IFI27, and EPSTI1) by logistic regression analysis and calculated the area under the ROC curve (AUC) for the diagnosis of COVID‐19. The AUC values of the training group, testing group, and entire group were 0.930, 0.914, and 0.921, respectively. The six genes were highly expressed in patients with COVID‐19 and positively correlated with the expression of SARS‐CoV‐2 invasion‐related genes (ACE2, TMPRSS2, CTSB, and CTSL). The risk score calculated by this model was also positively correlated with the expression of TMPRSS2, CTSB, and CTSL, indicating that the six genes were closely related to SARS‐CoV‐2 infection. In conclusion, we comprehensively analyzed the functions of DEGs in the blood leukocytes of patients with COVID‐19 and constructed a six‐gene model that may contribute to the development of new diagnostic and therapeutic ideas for COVID‐19. Moreover, these six genes may be therapeutic targets for COVID‐19.

as of March 22, 2021 . The top five countries with more than 1,000,000 cumulative confirmed cases of COVID-19 are the United States, India, Brazil, Russia, and France. 3 COVID-19 has already exceeded the total number of cases and deaths observed with atypical pneumonia (SARS-CoV in 2003) and the Middle East respiratory syndrome coronavirus (in 2012) because SARS-CoV-2 has a higher transmission rate. 4, 5 Therefore, it is crucial to analyze the current situation and study the impact of prevention and control measures separately for different epidemic situations in countries around the world.

Currently, quantitative real-time polymerase chain reaction (qRT-PCR) measurement of the SARS-CoV-2 nucleic acid is an important method for the diagnosis of COVID-19 in China to determine whether patients can be discharged from the hospital and/or need to enter isolation. 6 However, a negative qRT-PCR test result is not sufficient to exclude SARS-CoV-2 infection, and a combination of symptoms, radiological examination, and hematological examination are required to improve the sensitivity and accuracy of COVID-19 diagnosis. 7 Published studies have revealed that some hematological/biochemical changes in patients (e.g., normal or decreased leukocytes) may contribute to the diagnosis of COVID-19. 8, 9 After SARS-CoV-2 infection, immune cells are activated, which can result in a significant increase in immune cell infiltration into the lung tissue. These immune cells can secrete a large of inflammatory cytokines, resulting in a strong inflammatory response, namely, a "cytokine storm." This excessive inflammatory response can lead to many complications and even death. 10 By analyzing transcriptome sequencing data from peripheral blood samples, we can identify differentially expressed genes (DEGs) associated with host immune and/or inflammatory responses. Studying the changes in gene expression in human immune cells after SARS-CoV-2 infection helps improve understanding of the mechanism of SARS-CoV-2 damage to the human body and helps improve the diagnosis and treatment of the disease. [11] [12] [13] [14] Overmyer et al. 15 sequenced the leukocytes of patients with positive (n = 102) and negative (n = 102) SARS-CoV-2 tests and developed a COVID-19 severity prediction model through machine learning. The model's predictive ability was significantly better than that of the standard Charlson comorbidity index. Due to the advantage of easy access to blood samples, the development of predictive models based on blood leukocytes sequencing can be of great help for enhancing the diagnosis and treatment of COVID-19.

A recently published study performed whole-transcriptome RNA sequencing of 14 peripheral blood samples from COVID-19 patients (n = 10) and healthy donors (n = 4), from which researchers screened a large number of differentially expressed mRNAs and miRNAs and constructed a lncRNA-miRNA-mRNA regulatory network. 16 In addition, Arg1 has recently been found to be highly expressed in the peripheral blood leukocytes of COVID-19 patients and may be a diagnostic marker for COVID-19. 17 These studies contribute to the understanding of gene regulatory relationships and inflammatory mechanisms in the immune cells of COVID-19 patients and lay the foundation for the discovery of new diagnostic markers for COVID- 19 . However, at present, there are still few genomic studies on peripheral blood leukocytes in patients with COVID-19, and the mechanism of the abnormal inflammatory response to SARS-CoV-2 infection is still not fully understood.

In this study, we obtained a blood leukocytes RNA sequencing data set (GSE157103) of COVID-19 patients from the GEO database and performed differential expression analysis to obtain a large number of DEGs. We further screened the genes associated with SARS-CoV-2 infection using commonly used bioinformatics methods and constructed a six-gene model using logistic regression analysis.

We also analyzed the predictive ability of the model and the expression of the six genes to understand their expression regulation mechanism in COVID-19. Our findings provide a reliable six-gene model that might be helpful for the diagnosis and treatment of COVID-19. The objectives of this study were to explore aberrantly expressed genes related to SARS-CoV-2 infection in peripheral blood leukocytes and to develop a diagnostic model for COVID-19 using SARS-CoV-2 infection-related genes. These findings may advance human understanding of the mechanisms of the inflammatory response following SARS-CoV-2 infection and also contribute to the genome-wide search for promising targets for COVID-19 diagnosis and treatment.

The SARS-CoV-2-related sequencing data sets used in this study were all obtained from the GEO database (https://www.ncbi.nlm.nih. gov/geo/). We searched the GEO database using "SARS-CoV-2 or COVID-19" as keywords to obtain COVID-19-related data sets. The overall information about the data sets is shown in Table 1 . The GSE157103 data set sample origin is leukocytes from whole blood.

We used the limma package in R language to screen for DEGs The GSE156063 and GSE154104 data sets were used to analyze the expression of the finally obtained genes. 

We extracted the expression values of the genes in the selected module based on the GSE157103 data set. We randomly divided all samples in the GSE157103 data set into the training group and the testing group at a ratio of 7:3. A Χ 2 test was used to compare the characteristics of the patients between the two groups. We performed lasso regression analysis in the training group using the glmnet package in R language to calculate the coefficients of genes and removed genes with coefficients of 0.

The remaining genes were then used to construct a logistic regression model to determine whether patients were infected with SARS-CoV-2 by using the risk score formula: risk score = (Expression GENE1 × Coefficient GENE1 ) + (Expression GENE2 × Coefficient GENE2 ) + ⋯+(Expression GENEn × Coefficient GENEn ) + Coefficient Intercept . We applied the logistic regression formula obtained in the training group to the testing and entire groups to calculate the risk scores and used 0.5 as the cutoff value of the high-and low-risk groups. We used the pROC package to plot the ROC curve and calculate the area under the ROC curve (AUC), and we also performed principal component analysis (PCA) for each group. We calculated the sensitivity, specificity, negative predictive value, positive predictive value, and accuracy of the model in each group to assess the predictive performance of the model.

After constructing the model, we extracted data on the expression of the six genes from the GSE157103, GSE156063, and GSE154104 data sets. Moreover, the correlation between risk scores and the expression of SARS-CoV-2 invasion-related genes was analyzed in the GSE157103 data set. SARS-CoV-2 invasion-related genes were obtained from the Human Protein Atlas database (https://www.

proteinatlas.org/humanproteome/sars-cov-2). The above analyses were conducted using R language software 3.6.1 and results were considered significant at p < 0.05. 

We identified 245 DEGs in the GSE157103 data set based on the criteria mentioned above, including 226 upregulated DEGs and 19 downregulated DEGs ( Figure 1A ). The expression heat map is shown in Figure 1B . To understand the interaction between these DEGs, we used the STRING database to construct a PPI network.

After obtaining the PPI network data, we further used Cytoscape to perform a module analysis of the network (Table 2, Figure 2A ).

According to module analysis results, we selected the genes in the top two modules to perform GO functional annotation (biological process) to understand the roles of the two modules in SARS-CoV-2 infection. The analysis results showed that the genes in module 1 were mainly enriched in cell division function, while the genes in module 2 were mainly enriched in inflammation and the antiviral response ( Figure 2B ). The enrichment relationship between module 2 genes and GO functional annotations is shown in Figure 2C .

After GO functional annotation analysis of the genes in the two selected modules, we found that the genes in module 2 were related The training group had 69 COVID-19 patients, while the testing group had 31 COVID-19 patients. We found no difference after comparing the clinical characteristics of the two groups, indicating that the grouping results were reasonable (Table 3 ).

In the training group, six nonzero coefficient genes were ob- Figure 3B .

Finally, we used logistic regression to establish a six-gene model, 

We found a positive correlation between the average expression levels of six genes and the risk scores in the training group, testing group, and entire group (Figures 4A, 4D, 

We analyzed the expression of IFIT3, OASL, USP18, XAF1, IFI27, and EPSTI1 in the GSE157103 data set. The results showed that these six genes were differentially overexpressed in SARS-CoV-2-infected patients ( Figure 6A ), and the expression of these genes in ICU patients with SARS-CoV-2 infection was lower than that in non-ICU patients with SARS-CoV-2 infection ( Figure 6B ). Moreover, the expression of these six genes was not significantly different in terms of the sex and age of the SARS-CoV-2-infected patients ( Figures 6C and   6D ). We also analyzed the expression of these six genes in the GSE156063 data set. The results showed that the expression of these six genes in SARS-CoV-2-infected patients was significantly higher than that in patients without SARS-CoV-2 infection ( Figure 6E ). We also found that the expression levels of EPSTI1, IFI27, IFIT3, and OASL in patients with other viral infections were significantly higher than those in patients with SARS-CoV-2 infection ( Figure 6F ). This indicates that these six genes are highly expressed in upper airway samples and blood leukocytes of patients with COVID-19, and their expression may be different in patients with different severities of COVID-19.

To understand the expression relationship between these six genes and SARS-CoV-2 invasion-related genes (ACE2, TMPRSS2, CTSB, and CTSL), we performed a coexpression analysis using the GSE157103 and GSE156063 data sets and found that the expression of these six genes was positively correlated with the expression of ACE2, TMPRSS2, CTSB, and CTSL ( Figures 6G and 6H) . We also analyzed the expression of these six genes using SARS-CoV-2-infected mouse lung tissue sequencing data from the GSE154104 data set and found that the expression of five genes (IFIT3, USP18, XAF1, IFI27, and EPSTI1) increased after SARS-CoV-2 infection in mice (- Figure 6I ). Considering that the OASL gene probe is not present in the GSE154104 data set, we did not obtain expression data for OASL from this data set. This finding suggests that these five genes are highly expressed in the lung tissues of mice with COVID-19 and that this alteration in gene expression may be closely related to SARS-CoV-2 infection. The results indicate that the risk score calculated by the six-gene model may also be closely related to SARS-CoV-2 infection.

COVID-19 is spreading rapidly worldwide, and no specific drug has been developed for the treatment of this disease. 18 The results of routine blood examination of patients with COVID-19 typically show increased neutrophils and decreased lymphocytes. 19 As inflammatory activators, neutrophils may participate in the overactivation of the immune response and cytokine storm. The GEO database is a public database that consists of a variety of sequencing data sets. 21 In this study, we obtained the COVID-19- an interferon-responsive gene, has been identified as an oncogene in human breast cancer. 29 One study found that EPSTI1 is a regulator of macrophage activation and polarization through the Stat1 and p65 pathways and regulates the inflammatory response in a mouse model. 30 OASL is widely considered to play an important role in antiviral defense mechanisms and is an interferon-stimulating gene. 31 The results of the single-cell sequencing analysis of neutrophils and inflammatory macrophages showed that the expression In conclusion, this study comprehensively analyzed the blood leukocytes gene expression profile data of COVID-19 patients by using bioinformatics methods and provided a preliminary understanding of the functions and mechanisms of DEGs in the leukocytes of COVID-19 patients. We also constructed a six-gene model that may contribute to the diagnosis and treatment of COVID-19. The high expression of the six genes (IFIT3, OASL, USP18, XAF1, IFI27, and EPSTI1) in this model was closely related to SARS-CoV-2 infection, and these six genes may be used as diagnostic markers and therapeutic targets for COVID-19. Our study revealed the function of these six genes in COVID-19, which lays a foundation for the further study of the inflammatory mechanisms of the disease. However, the limitation of this study is that the sample size was small, and larger sample size is needed in the future to verify the diagnostic ability of the six-gene model and the function of the included genes.

The authors thank the National Center for Biotechnology Information (NCBI) for its public data sets and its contribution to the fight against COVID-19. Dr. Xin Gao also acknowledged his mother, Kuanfeng Xiang, for her support during the difficult time in his work and life. Here, Dr. Gao wishes his mother a healthy and happy life. This study was supported by the school-level scientific research project of Jishou University (Jdlc2021).

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

COVID-19, modern pandemic: a systematic review from front-line health care providers' perspective

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. 2021

Clinical characteristics, diagnosis, and treatment of major coronavirus outbreaks

Zoonotic origins of human coronaviruses

Genetic analysis of the 2019 coronavirus pandemic with from real-time reverse transcriptase polymerase chain reaction

Differential diagnosis and prospective grading of COVID-19 at the early stage with simple hematological and biochemical variables

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

A review on how to do hematology consults during COVID-19 pandemic

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Differential microRNA expression in the peripheral blood from human patients with COVID-19

Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes

Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease

A predictive model for the severity of COVID-19 in elderly patients

Large-scale multi-omic analysis of COVID-19 severity

Whole-transcriptome RNA sequencing reveals significant differentially expressed mRNAs, miR-NAs, and lncRNAs and related regulating biological pathways in the peripheral blood of COVID-19 patients

Arginase 1 (Arg1) as an up-regulated gene in COVID-19 patients: a promising marker in COVID-19 immunopathy

Pharmacotherapy for hospitalized patients with COVID-19: treatment patterns by disease severity

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

Elevated serum ferritin level effectively discriminates severity illness and liver injury of coronavirus disease 2019 pneumonia

Corona Virus Disease 2019 patients with different disease severity or age range: a single-center study of clinical features and prognosis

A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity

Coagulopathy in patients with COVID-19: a systematic review and meta-analysis

IFIT3 and IFIT2/3 promote IFIT1-mediated translation inhibition by enhancing binding to nonself RNA

Single-cell transcriptome analysis highlights a role for neutrophils and inflammatory macrophages in the pathogenesis of severe COVID-19

Protein coding and long noncoding RNA (lncRNA) transcriptional landscape in SARS-CoV-2 infected bronchial epithelial cells highlight a role for interferon and inflammatory response

Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment

Regulation of inflammatory gene expression in macrophages by epithelial-stromal interaction 1 (Epsti1)

2'−5'-Oligoadenylate synthetaselike protein inhibits intracellular M. tuberculosis replication and promotes proinflammatory cytokine secretion

Suppression of USP18 potentiates the anti-HBV activity of interferon alpha in HepG2.2.15 cells via JAK/STAT signaling

UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity

X-linked inhibitor of apoptosis-associated factor 1 regulates TNF receptor 1 complex stability

Single-cell sequencing of peripheral mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Amantadine disrupts lysosomal gene expression: a hypothesis for COVID19 treatment

The authors declare that there are no conflict of interests.

Xin Gao designed the study, performed data analysis work, and aided in